Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Income Statement [Abstract]    
Revenue
Operating costs and expenses:    
Research and development expenses (including non-cash share-based compensation expenses of $489 and $505, respectively) 1,349 1,068
General and administrative expenses (including non-cash share-based compensation expenses of $771 and $558, respectively) 2,260 1,488
Total operating costs and expenses 3,609 2,556
Loss from operations (3,609) (2,556)
Interest income 319 202
Net loss (3,290) (2,354)
Less: Net loss attributable to noncontrolling interest (35) (32)
Net loss attributable to common shareholders $ (3,255) $ (2,322)
Net loss per common share attributable to common shareholders:    
Basic $ 0.10 $ 0.08
Diluted $ 0.10 $ 0.08
Weighted average common shares outstanding:    
Basic 31,446 30,921
Diluted 31,446 30,921